Literature DB >> 11062522

Parkinson disease gene therapy moves toward the clinic.

A Björklund1, O Lindvall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11062522     DOI： 10.1038/81291

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

1.  Identification of a novel proliferation-inducing determinant using lentiviral expression cloning.

Authors:  Dmitri Chilov; Cornelia Fux; Hana Joch; Martin Fussenegger
Journal:  Nucleic Acids Res       Date:  2003-09-15       Impact factor: 16.971

2.  Pharmacological MRI (phMRI) monitoring of treatment in hemiparkinsonian rhesus monkeys.

Authors:  Liming Luan; Feng Ding; Yi Ai; Anders Andersen; Peter Hardy; Eric Forman; Greg A Gerhardt; Don M Gash; Richard Grondin; Zhiming Zhang
Journal:  Cell Transplant       Date:  2008       Impact factor: 4.064

3.  An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease.

Authors:  H Mochizuki; H Hayakawa; M Migita; M Shibata; R Tanaka; A Suzuki; Y Shimo-Nakanishi; T Urabe; M Yamada; K Tamayose; T Shimada; M Miura; Y Mizuno
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

Review 4.  Immortalization of neuronal progenitors using SV40 large T antigen and differentiation towards dopaminergic neurons.

Authors:  A Alwin Prem Anand; S Gowri Sankar; V Kokila Vani
Journal:  J Cell Mol Med       Date:  2012-11       Impact factor: 5.310
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.